3003新葡的京集团
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2020.02.25
2020年公开发行公司债券(疫情防控债)募集说明书(面向合格投资者)
2020.02.25
2020年公开发行公司债券(疫情防控债)募集说明书摘要(面向合格投资者)
2020.02.25
2020年公开发行公司债券(疫情防控债)发行公告(面向合格投资者)
2020.02.12
第四届董事会第二十九次会议决议公告
2020.02.12
第四届监事会第二十二次会议决议
2020.02.12
关于召开2020年第一次临时股东大会的通知公告
2020.02.12
关于向中行申请内保外贷暨提供反担保的公告
2020.02.05
关于参股公司新药研发进展的提示性公告
2020.02.03
关于第三期员工持股计划锁定期届满的公告
2020.01.23
关于向香港联交所递交境外上市外资股(H股)上市申请并刊发申请版本资料集的公告
第一页
上一页
39
40
41
42
43
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.